A pipeline for testing drug mechanism of action and combination therapies: From microarray data to simulations via Linear-In-Flux-Expressions: Testing four-drug combinations for tuberculosis treatment.

[1]  Nathaniel J. Merrill,et al.  History and Future Perspectives on the Discipline of Quantitative Systems Pharmacology Modeling and Its Applications , 2021, Frontiers in Physiology.

[2]  S. Muldoon,et al.  Quantitative systems pharmacology in neuroscience: Novel methodologies and technologies , 2021, CPT: pharmacometrics & systems pharmacology.

[3]  O. Blin,et al.  Innovative approaches in CNS clinical drug development: Quantitative systems pharmacology. , 2020, Therapie.

[4]  Diego Alonso-López,et al.  Systematic comparison and assessment of RNA-seq procedures for gene expression quantitative analysis , 2020, Scientific Reports.

[5]  Qing Tan,et al.  Hypergraph models of biological networks to identify genes critical to pathogenic viral response , 2020, BMC Bioinform..

[6]  N. Penner,et al.  Phase II Dose Selection for Alpha Synuclein–Targeting Antibody Cinpanemab (BIIB054) Based on Target Protein Binding Levels in the Brain , 2020, CPT: pharmacometrics & systems pharmacology.

[7]  L. Marchetti,et al.  A QSP model of prostate cancer immunotherapy to identify effective combination therapies , 2020, Scientific Reports.

[8]  Benedetto Piccoli,et al.  Metabolic graphs, LIFE method and the modeling of drug action on Mycobacterium tuberculosis , 2020, 2003.12400.

[9]  Rhys D O Jones,et al.  Applications of Quantitative Systems Pharmacology in Model‐Informed Drug Discovery: Perspective on Impact and Opportunities , 2019, CPT: pharmacometrics & systems pharmacology.

[10]  Minoru Kanehisa,et al.  New approach for understanding genome variations in KEGG , 2018, Nucleic Acids Res..

[11]  Benedetto Piccoli,et al.  Stability of metabolic networks via Linear-in-Flux-Expressions , 2018, Networks Heterog. Media.

[12]  L. Blank,et al.  Using quantitative systems pharmacology to evaluate the drug efficacy of COX-2 and 5-LOX inhibitors in therapeutic situations , 2018, npj Systems Biology and Applications.

[13]  Jing Li,et al.  Quantitative Systems Pharmacology Modeling of Acid Sphingomyelinase Deficiency and the Enzyme Replacement Therapy Olipudase Alfa Is an Innovative Tool for Linking Pathophysiology and Pharmacology , 2018, CPT: pharmacometrics & systems pharmacology.

[14]  Benedetto Piccoli,et al.  Equilibria for Large Metabolic Systems and the LIFE Approach , 2018, 2018 Annual American Control Conference (ACC).

[15]  I. Trocóniz,et al.  A systems pharmacology model for inflammatory bowel disease , 2018, PloS one.

[16]  Sean T. McQuade,et al.  Linear-In-Flux-Expressions Methodology: Toward a Robust Mathematical Framework for Quantitative Systems Pharmacology Simulators , 2017, Gene regulation and systems biology.

[17]  Christina M. Friedrich,et al.  A Quantitative Systems Pharmacology Platform to Investigate the Impact of Alirocumab and Cholesterol-Lowering Therapies on Lipid Profiles and Plaque Characteristics , 2017, Gene regulation and systems biology.

[18]  Minoru Kanehisa,et al.  KEGG: new perspectives on genomes, pathways, diseases and drugs , 2016, Nucleic Acids Res..

[19]  V. Chelliah,et al.  The promises of quantitative systems pharmacology modelling for drug development , 2016, Computational and structural biotechnology journal.

[20]  K. Gadkar,et al.  Quantitative systems pharmacology: a promising approach for translational pharmacology. , 2016, Drug discovery today. Technologies.

[21]  Nathan D. Price,et al.  Integrated Modeling of Gene Regulatory and Metabolic Networks in Mycobacterium tuberculosis , 2015, PLoS Comput. Biol..

[22]  MC Peterson,et al.  FDA Advisory Meeting Clinical Pharmacology Review Utilizes a Quantitative Systems Pharmacology (QSP) Model: A Watershed Moment? , 2015, CPT: pharmacometrics & systems pharmacology.

[23]  J. Palomino,et al.  Drug Resistance Mechanisms in Mycobacterium tuberculosis , 2014, Antibiotics.

[24]  H. Bersini,et al.  A Measure of the Signal-to-Noise Ratio of Microarray Samples and Studies Using Gene Correlations , 2012, PloS one.

[25]  T. Myers,et al.  The Transcriptional Responses of Mycobacterium tuberculosis to Inhibitors of Metabolism , 2004, Journal of Biological Chemistry.

[26]  John A. Jacquez,et al.  Qualitative Theory of Compartmental Systems , 1993, SIAM Rev..

[27]  Y. Ohta,et al.  Asymptotic behavior of nonlinear compartmental systems: Nonoscillation and stability , 1978 .

[28]  R. Chaisson,et al.  Executive Summary: Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[29]  Ravi Iyengar,et al.  Quantitative and Systems Pharmacology in the Post-genomic Era : New Approaches to Discovering Drugs and Understanding Therapeutic , 2011 .

[30]  Susumu Goto,et al.  KEGG: Kyoto Encyclopedia of Genes and Genomes , 2000, Nucleic Acids Res..